$GNCP NEW YORK, March 13, Mar 13, 2013 (GLOBE NEWSWIRE

New Post Public Reply Private Reply Replies (0) Message Board
jstops

[b]$GNCP[/b] NEW YORK, March 13,[b] [color=blue]Mar 13, 2013[/color][/b] (GLOBE NEWSWIRE via COMTEX) -- GNCC Capital, Inc. (Pink Sheets:GNCP) ("the Company") announced on March 1, 2013 that it was evaluating the potential acquisition of a Gold Exploration Property which is significantly larger than any exploration property in its present portfolio.

The Company is at this time awaiting the final purchase terms that are acceptable to the vendors. This includes Work Commitments, Net Smelter Revenues and other royalties. Should this acquisition be consummated, it will be funded through the issuance of a combination of new Preferred Stock in the Company and long term Loan Notes. The Company remains committed to its long standing pledge not to issue additional shares of its Common Stock.


This Gold Exploration property has had very satisfactory assay results from previous drilling programs and qualifies for far more extensive geological research and a systematic drilling program.


The Company recently announced that it has entered into a Line of Credit Agreement with Diamond Peak Resource Corporation ("Diamond Peak") in the amount of $1,000,000 primarily for the immediate and accelerated development of the Company's Mining Exploration Properties.


Should the Company complete this acquisition, it has the ability to increase the amount of this Credit Facility from Diamond Peak and source additional credit facilities should it so require.


The Company will continue to update stockholders as to the status of this acquisition.


About GNCC Capital, Inc.:


GNCC Capital, Inc. is primarily a Gold Exploration Company, with a secondary focus on Silver Exploration. The initial exploration properties are located in Arizona and consist of "Esther Basin, Burnt Well, Clara, Kit Carson, Silverfields and Potts Mountain". The Company intends to create significant value for its initial portfolio of properties through continued exploration, joint ventures, and through the acquisition of additional Gold and Silver Exploration assets. GNCC Capital, Inc. is a current information filer on the OTC Markets under the symbol "GNCP'.


The GNCC Capital, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=17259

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Madrigal Pharmaceuticals Rewards New Employees with Equity Awards

Updated Category News Views 100

Overview of Equity Inducement Awards Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a leading biopharmaceutical organization, has recently initiated equity inducement awards to welcome new talent to its dynamic team. This initiative demonstrates Madrigal's commitment to fostering a strong workforce geared towards tackling significant health challenges related to metabolic...

Continue Reading
Boston Metal Welcomes Roy Harvey to Enhance Board Leadership

Updated Category News Views 202

Boston Metal Appoints Industry Leader Roy Harvey Boston Metal, a prominent technology company that is transforming the landscape of global metals production, has made a significant move by appointing Roy Harvey to its Board of Directors. This decision is pivotal as Boston Metal gears up for the commercial rollout of its groundbreaking Molten Oxide Electrolysis (MOE)...

Continue Reading
RBL LLC Partners with Carnrite Ventures for Biotech Growth

Updated Category News Views 125

RBL LLC Partners with Carnrite Ventures for Biotech Growth RBL LLC, a leading biotech venture creation studio, is excited to announce a significant investment from Carnrite Ventures. This partnership aims to enhance the rapid development of their robust pipeline of innovative therapeutic companies. According to Paul Wotton, the managing partner at RBL, "Carnrite's...

Continue Reading
OncoC4 and AcroImmune Merger: A Milestone in Immunotherapy

Updated Category News Views 106

Introducing the OncoC4 and AcroImmune Merger OncoC4, Inc. has just announced a thrilling merger with AcroImmune, a strategic union that promises to significantly boost OncoC4's standing in the biopharmaceutical sector. This collaboration brings together two companies dedicated to pioneering advancements in cancer treatment, with a special focus on developing unique...

Continue Reading
Rezolve AI Celebrates Major Investment Transforming AI Landscape

Updated Category News Views 92

Rezolve AI Excited About $30 Billion AI Investment Rezolve AI (NASDAQ: RZLV), well-known for its cutting-edge AI-driven commerce solutions, is enthusiastic about the recent announcement from Microsoft and BlackRock. These influential tech companies plan to invest $30 billion into AI infrastructure, a decision that could profoundly alter the landscape of the artificial...

Continue Reading